What is coagulation factor VIIa recombinant?

Factor VIIa is a synthetic protein produced to replicate the activated factor VII (factor VIIa) in the body that promoes clotting. It is used to stop bleeding from injuries or surgical procedures for patients with hemophilia by helping the blood to clot. Factor VIIa is to be given only by or under the direct supervision of a doctor.

How does recombinant factor VIIa work?

Recombinanat factor VIIa activates factors IX and X, which in turn activates factor V, which converts prothrombin to thrombin. Thrombin creates a thrombin burst, which converts fibrinogen to fibrin for clot formation

What is the half life of recombinant factor VIIa?

Studies in adults showed that the circulating half-life of rfVIIa is between 2.60 to 2.84 hours, independent of dose.

What are the differences between hemophilia A and B?

Hemophilia A and B are both the results of a deficiency in blood clotting factors. Hemophilia A is caused by a deficiency of factor VIII, while Hemophilia B is caused by a deficiency of factor IX.

How is hemophilia inherited?

Both forms of hemophilia (A and B) are X-linked recessive disorders, which means they are more common in males and can only be inherited from maternal grandfathers who have the faulty gene. Mothers who inherit the gene from their fathers don't have any symptoms. Very rarely, a gene mutation can occur, which could start a new line of inheritance. This is believed to have happened in the case of Queen Victoria, who passed the gene on to many of the males in the royal families of Europe in the 19th century.

Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Home / Online Pharmacy / Novoseven RT

For visual reference only; actual product may vary

US Name:

Novoseven RT
Alternative Names:

Novoseven RT
Active Ingredients:

Eptacog Alfa - Recombinant Activated Factor VII (rFVIIa)
Brand Manufacturer:

Novo Nordisk
Manufacturer Location:

Denmark
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

Novoseven RT ^*

For visual reference only; actual product may vary

Prescription Required

All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

NovoSeven RT is an injectable medication used to control bleeding episodes and prevent bleeding during surgeries and procedures in adults and children with specific bleeding disorders such as hemophilia.

Place your order

Novoseven RT Brand	2mg/vial 1 Vial	- Novoseven RT – Brand, Novoseven RT, 2mg/vial, 1, Vial, 35599, NovoNordisk, 2668 + 0	Our price: $1,460.00
Novoseven RT Brand	1mg/vial 1 Vial	- Novoseven RT – Brand, Novoseven RT, 1mg/vial, 1, Vial, 35598, NovoNordisk, 2667 + 0	Our price: $730.00

*Please note all prices are in US dollars

Description
Side Effects
Indications
FAQ
Video

NovoSeven RT (generic name: recombinant coagulation Factor VII) is an injectable medication used to control bleeding episodes and prevent bleeding during surgeries and procedures in adults and children with specific bleeding disorders. These include hemophilia A or B with inhibitors, congenital Factor VII deficiency, and Glanzmann’s thrombasthenia. It may also be used during the treatment of bleeding and to prevent bleeding in adults with acquired hemophilia who are undergoing surgery and procedures.

Recombinant coagulation factor VIIa (rFVIIa) is a man-made protein designed to mimic the natural clotting factor VIIa in the body, used to help blood clot. It’s particularly important for treating bleeding episodes in individuals with hemophilia who have developed antibodies against traditional clotting factors. rFVIIa is also used in other conditions where traditional hemostatic measures are insufficient.

Dosage

NovoSeven RT is administered by injection. Patients who have been trained may be able to self-administer. Otherwise, it should be done only in a clinical environment under the supervision of a healthcare provider.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.

NovoSeven RT may cause serious blood clots that form in veins and arteries. Doctors should have discussed the risks and explained the signs and symptoms of blood clots. Some of these include pain, swelling, warmth, redness, or a lump in the legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function. Healthcare providers usually monitor patients for signs of blood clots during treatment.

Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include fever, headache, dizziness, nausea, or vomiting may occur.

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Patients who have blood-clotting disorders such as hemophilia types A and B may require special blood-clotting facilitation if they have uncontrolled bleeding episodes after injury or are having to underego surgical procedures. Factor VIIa is a man-made protein that mimics the naturally occurring clotting activator in the body. It is used to stop bleeding in patients by helping the blood to clot.

Factor VIIa is a synthetic protein produced to replicate the activated factor VII (factor VIIa) in the body that promoes clotting. It is used to stop bleeding from injuries or surgical procedures for patients with hemophilia by helping the blood to clot. Factor VIIa is to be given only by or under the direct supervision of a doctor.
Both forms of hemophilia (A and B) are X-linked recessive disorders, which means they are more common in males and can only be inherited from maternal grandfathers who have the faulty gene. Mothers who inherit the gene from their fathers don't have any symptoms. Very rarely, a gene mutation can occur, which could start a new line of inheritance. This is believed to have happened in the case of Queen Victoria, who passed the gene on to many of the males in the royal families of Europe in the 19th century.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.